Drug – bio-affecting and body treating compositions – Enzyme or coenzyme containing – Hydrolases
Reexamination Certificate
2002-02-26
2004-02-10
Saidha, Tekchand (Department: 1652)
Drug, bio-affecting and body treating compositions
Enzyme or coenzyme containing
Hydrolases
C435S195000, C435S196000, C435S252300, C435S320100, C435S911000, C435S916000, C435S471000, C536S023200, C536S023700, C530S350000
Reexamination Certificate
active
06689358
ABSTRACT:
FIELD OF THE INVENTION
This invention relates to variants of phytases, in particular variants of ascomycete phytases and variants of basidiomycete phytases, the corresponding cloned DNA sequences, a method of producing such phytase variants, and the use thereof for a number of industrial applications.
BACKGROUND OF THE INVENTION
Phytic acid or myo-inositol 1,2,3,4,5,6-hexakis dihydrogen phosphate (or for short myo-inositol hexakisphosphate) is the primary source of inositol and the primary storage form of phosphate in plant seeds. Phytin is a mixed potassium, magnesium and calcium salt of inositol.
The phosphate moieties of phytic acid chelates divalent and trivalent cations such as metal ions, i.a. the nutritionally essential ions of calcium, iron, zinc and magnesium as well as the trace minerals manganese, copper and molybdenum.
Phytic acid and its salts, phytates, are often not metabolized, i.e. neither the phosphorous thereof, nor the chelated metal ions are nutritionally available.
Accordingly, food and feed preparations need to be supplemented with inorganic phosphate and often also the nutritionally essential ions such as iron and calcium, must be supplemented.
Still further, the phytate phosphorus passes through the gastrointestinal tract of such animals and is excreted with the manure, resulting in an undesirable phosphate pollution of the environment resulting e.g. in eutrophication of the water environment and extensive growth of algae.
Phytic acid or phytates, said terms being, unless otherwise indicated, in the present context used synonymously or at random, are degradable by phytases.
The production of phytases by plants as well as by microorganisms has been reported. Amongst the microorganisms, phytase producing bacteria as well as phytase producing fungi are known.
There are several descriptions of phytase producing filamentous fungi belonging to the fungal phylum of Ascomycota (ascomycetes). In particular, there are several references to phytase producing ascomycetes of the Aspergillus genus such as
Aspergillus terreus
(Yamada et al., 1986, Agric. Biol. Chem. 322:1275-1282). Also, the cloning and expression of the phytase gene from
Aspergillus niger
var.
awamori
has been described (Piddington et al., 1993, Gene 133:55-62). EP 0420358 describes the cloning and expression of a phytase of
Aspergillus ficuum
(niger). EP 0684313 describes the cloning and expression of phytases of the ascomycetes
Aspergillus niger, Myceliophthora thermophila, Aspergillus terreus
. Still further, some partial sequences of phytases of
Aspergillus nidulans, Talaromyces thermophilus, Aspergillus fumigatus
and another strain of
Aspergillus terreus
are given.
The cloning and expression of a phytase of
Thermomyces lanuginosus
is described in WO 97/35017.
There is a current need for phytases of amended properties or characteristics, e.g. phytases of increased thermostability, altered pH optimum (a high pH optimum being desirable for in-vitro processing, a low for in-vivo processing in the gastro-intestinal tract), and/or of a higher specific activity.
SUMMARY OF THE INVENTION
In a first aspect, the invention provides phytase variants, the characteristics of which are amended—as compared to a so-called model phytase.
Any model phytase, which is of a certain similarity to thirteen herein specifically disclosed model phytases, can be made the model of such variants.
In another aspect, the invention relates to a novel phytase derived from
Cladorrhinum foecundissimum.
In still another aspect, the invention provides DNA sequences encoding these phytase variants and this phytase, and methods of their production.
Finally, the invention also relates generally to the use of the phytase and the phytase variants for liberating phosphorous from any phytase substrate, in particular inorganic phosphate from phytate or phytic acid.
REFERENCES:
patent: 6060298 (2000-05-01), Lassen et al.
patent: 6153418 (2000-11-01), Lehmann
patent: 6514498 (2003-02-01), Svendsen et al.
patent: 0 420 358 (1991-04-01), None
patent: 0 684 313 (1995-11-01), None
patent: 0 897 010 (1999-02-01), None
patent: 0 897 985 (1999-02-01), None
patent: 91/14782 (1991-10-01), None
patent: 97/35016 (1997-09-01), None
patent: 97/35017 (1997-09-01), None
patent: 97/48812 (1997-12-01), None
Yamada et al., 1986, Agric. Biol. Chem. vol. 32, No. 10, p. 1275-1282(1968).
Piddington, C.S. et al., Gene. Vol. 133: P.55-62(1993).
Kostrewa Dirk
Lassen Søren Flensted
Lehmann Martin
Pasamontes Luis
Svendsen Allan
Lambiris Elias J.
Novozymes A/S
Saidha Tekchand
LandOfFree
Phytase variants does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phytase variants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phytase variants will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3313140